Partial Breast Versus no Irradiation for Women With Early Breast Cancer

Abroad (travel likely)Recruiting

Conditions

Local Neoplasm Recurrence · Distantly Metastatic Malignant Neoplasm · Death · Fibrosis Breast · Depigmentation/Hyperpigmentation of Skin · Telangiectasia · Scar · Pain · PROMs

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Ponticia Universidad Catolica de Chile, Santiago, Chile

    Contact: Study coordinator (Tomas Merino Lara)
  • Aalborg University Hospital, Aalborg, Denmark

    Contact: Study coordinator (Tamas Lörinz, MD)
  • Aarhus University Hospital, Aarhus, Denmark

    Contact: Study coordinator (Hanne M Nielsen, PhD)
  • Rigshospitalet, Copenhagen, Denmark

    Contact: Study coordinator (Claus Kamby, DMSc)
  • Herlev Hospital, Herlev, Denmark

    Contact: Study coordinator (Louise W Matthiessen)
  • Naestved Hospital, Næstved, Denmark

    Contact: Study coordinator (Sami Al-Rawi, MD)
  • Odense University Hospital, Odense, Denmark

    Contact: Study coordinator (Mette H Nielsen, PhD)
  • Vejle Hospital, Vejle, Denmark

    Contact: Study coordinator (Troels Bechmann, PhD)
  • Haukeland HUS, Bergen, Norway

    Contact: Study coordinator (Hans Petter Eikesdal)
  • Nordlandssykehuset, Bodø, Norway

    Contact: Study coordinator (Bård Mannsåker)
  • Kristiansand Hospital, Kristiansand, Norway

    Contact: Study coordinator (Unn-Miriam Kasti)
  • Oslo University Hospital, Radiumhospitalet, Oslo, Norway

    Contact: Study coordinator (Kristin Reinertsen)
  • Stavanger Hospital, Stavanger, Norway

    Contact: Study coordinator (Ingvil Mjaaland)
  • Tromsø University Hospital, Tromsø, Norway

    Contact: Study coordinator (Egil Blix Støre)
  • Sahlgrenska University hospital, Gothenburg, Sweden

    Contact: Study coordinator (Dan Lundstedt)
  • Skånes University Hospital, Lund, Sweden

    Contact: Study coordinator (Sara Alkner)
  • Uppsala Akademiska Sjukhuset, Uppsala, Sweden

    Contact: Study coordinator (Henrik Lindman)
Study leads
  • Birgitte V Offersen, PhD

    Principal Investigator

    Danish Breast Cancer Group